065660 — Anterogen Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩137bn
- KR₩97bn
- KR₩7bn
- 47
- 17
- 25
- 15
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,148 | 4,151 | 8,122 | 6,591 | 6,500 |
Cost of Revenue | |||||
Gross Profit | 1,661 | 1,742 | 3,872 | 2,616 | 2,666 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8,874 | 6,893 | 10,755 | 11,221 | 11,957 |
Operating Profit | -4,726 | -2,742 | -2,633 | -4,630 | -5,457 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4,050 | -4,375 | -554 | -6,850 | -2,841 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4,050 | -4,375 | -554 | -6,837 | -2,841 |
Net Income Before Extraordinary Items | |||||
Net Income | -4,050 | -4,375 | -554 | -6,837 | -2,841 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -4,050 | -4,375 | -554 | -6,837 | -2,841 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -261 | -588 | -95.6 | -709 | -253 |
Dividends per Share |